Observational analysis shows that Lactiplantibacillus plantarum and epicatechin reduce hyperuricemia in models, indicating potential for gut microbiota modulation.
Lactiplantibacillus plantarum MPB-65 combined with epicatechin alleviates hyperuricemia by inhibiting xanthine oxidase activity, modulating the expressions of uric acid transporters, regulating gut microbiota dysregulation and enhancing SCFAs levels.
No takes yet. Share an insight, caveat, or question.
Tian et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: